ArticleActive
Billing and Coding: MolDX: Molecular Testing for Identification and Management of Hereditary Transthyretin Amyloidosis
A59861
Updated: December 31, 2025
Policy Summary
Billing for MolDX molecular testing for hereditary transthyretin amyloidosis requires selection of the appropriate CPT and ICD-10-CM codes, reporting the DEX Z‑Code adjacent to the CPT code in specified claim fields for Part A and Part B, and entering 1 unit of service. Only one test may be billed per patient and DEX Z‑Codes entered on SV101-7 must not include additional characters.
Coverage Criteria Preview
Key requirements from the full policy
"Only one molecular test for hereditary transthyretin (TTR) amyloidosis may be billed per patient."
Sign up to see full coverage criteria, indications, and limitations.